Cargando…
The Future of Intravesical Drug Delivery for Non-Muscle Invasive Bladder Cancer
Despite being the fifth most common cancer in the United States, minimal progress has been made in the treatment of bladder cancer in over a decade. Intravesical instillation of Bacillus Calmette-Guerin (BCG) for the treatment of non-muscle invasive bladder cancer (NMIBC) has been in use for over 30...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969694/ https://www.ncbi.nlm.nih.gov/pubmed/27500196 http://dx.doi.org/10.3233/BLC-160056 |